GB1012794A - New steroids and methods of producing same - Google Patents
New steroids and methods of producing sameInfo
- Publication number
- GB1012794A GB1012794A GB1821162A GB1821162A GB1012794A GB 1012794 A GB1012794 A GB 1012794A GB 1821162 A GB1821162 A GB 1821162A GB 1821162 A GB1821162 A GB 1821162A GB 1012794 A GB1012794 A GB 1012794A
- Authority
- GB
- United Kingdom
- Prior art keywords
- keto
- group
- steroid
- reacting
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises steroids of the general formula <FORM:1012794/C2/1> wherein R3 represents a 3-keto-D 4-system, a D 3,5-enol ether system or a D 3,5-enol ester system, R6 represents a hydrogen, fluorine or chlorine atom in the a ,b or planar position, Rb represents a double bond between carbon atoms 6 and 7 when R3 is a 3-keto-D 4-system and nb represents 0 or 1, R17 represents a b -hydroxy group or an etherified or esterified b -hydroxy group and R117 represents an alkenyl group bonded in the a -position containing from 3 to 6 carbon atoms, and the preparation thereof by reacting a corresponding 17-keto compound, or such compound containing a protected 3-keto group, with an alkenyl or alkynyl magnesium halide or alkali metal alkynyl compound containing from 3 to 6 carbon atoms and hydrolysing the initial reaction product and, when an alkynyl magnesium halide or alkali metal alkynyl compound is used, hydrogenating the resulting 17b -hydroxy-17a -alkynyl-steroid to form the 17a -alkenyl radical, or by reacting a corresponding 17-keto compound, or such compound containing a 3-protected keto group, with an alkali metal acetylide containing from 2 to 5 carbon atoms having a free hydrogen atom attached to a triply-bound carbon atom, hydrolysing the resulting reaction product, reacting with an alkali metal to replace the aforesaid free hydrogen atom by an alkali metal, reacting the product with an alkyl halide containing from 1 to 4 carbon atoms such that the resulting group attached to the 17-position contains from 3 to 6 carbon atoms and hydrogenating the product to convert the triple bond into a double bond, or by reacting a corresponding 17-keto compound or such compound containing a protected 3-keto group with a lithium alkenyl containing from 3 to 8 carbon atoms in which the lithium atom is bound to a saturated carbon atom. Any of the above processes may be modified in that before or after introducing the 17a -alkenyl group the 6-position of the steroid nucleus is substituted by a chlorine or fluorine atom by reacting the required steroid containing a 3-keto-D 4-system with N-chloro-succinimide or other N-chloro-imide or by reacting the required steroid containing a 3-enol ether or 3-enol ester D 3,5-system with perchloryl fluoride, an N - chloro - imide or chlorine or by epoxidizing a 3-keto-D 4,6-system and treating the resulting 3-keto-D 4-6,7-epoxide system with hydrogen chloride or hydrogen fluoride, or a 6-double bond is introduced by dehydrogenating the required steroid containing a 3-keto-D 4-system with chloranil or by dehydrohalogenatin the required 3-keto-D 4-6-halo-steroid with an organic or inorganic base, or by oxidizing the required 3-hydroxy-D 3,5-steroid according to the Oppenauer method in the presence of a quinone. The 3-keto group may be protected in the above processes by conversion to a 3-anamine, 3-enolether, 3-enolester or 3-ketol group, for example, by reaction with a secondary amine such as pyrrolidine or piperidine, or an aliphatic diol. The 17b -hydroxy group in the product of any of the above processes may be acylated for example, with a mono- or di-carboxylic acid or an anhydride or acid halide thereof, or may be etherified with an organo-halide. Ester groups derived from carboxylic acids may be further substituted by one or more halogen atoms, amino groups or sulphonic acid groups. The 3-keto-D 4-system may also be formed by acid and/or alkaline hydrolysing a D 3 5-3-enolester or a D 3,5-3-enolether system, by reducing a 3-keto-D 4,6-system either by catalytic hydrogenation or by means of an alkali metal and liquid ammonia, if desired, followed by acid or alkaline isomerisation of the intermediately formed 3-keto-D 5-system, by oxidizing a 3-hydroxy-D 4- or 3-hydroxy-D 5-system by the Oppenhauer method, by means of manganese dioxide or by the action of 2,3-dichloro-5,6-dicyano-benzoquinone, or by halogenating a 3-keto-ring A saturated system at C4 and dehydrohalogenatin the resulting 3-keto-4-halo-system. Pharmaceutical compositions which may be in the form of tablets, pills, powders, and injectable solutions contain as the active ingredient a steroid of the above general formula. Specification 912,200 is referred to.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1821162A GB1012794A (en) | 1962-05-11 | 1962-05-11 | New steroids and methods of producing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1821162A GB1012794A (en) | 1962-05-11 | 1962-05-11 | New steroids and methods of producing same |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1012794A true GB1012794A (en) | 1965-12-08 |
Family
ID=10108564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1821162A Expired GB1012794A (en) | 1962-05-11 | 1962-05-11 | New steroids and methods of producing same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1012794A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2059516A1 (en) * | 1969-07-16 | 1971-06-04 | Philips Nv | |
US4171317A (en) * | 1978-03-27 | 1979-10-16 | Henkel Corporation | Selective conversion of 20-methylpregna-3,5,20(21)-triene-3,21-diol-diacetate to 3-oxo-20-methylpregna-4,20(21)-diene-21-yl-acetate |
-
1962
- 1962-05-11 GB GB1821162A patent/GB1012794A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2059516A1 (en) * | 1969-07-16 | 1971-06-04 | Philips Nv | |
US4171317A (en) * | 1978-03-27 | 1979-10-16 | Henkel Corporation | Selective conversion of 20-methylpregna-3,5,20(21)-triene-3,21-diol-diacetate to 3-oxo-20-methylpregna-4,20(21)-diene-21-yl-acetate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3445489A (en) | 9beta,10alpha-steroids,intermediates therefor and pharmaceutical preparations containing these compounds as an active ingredient | |
GB1012794A (en) | New steroids and methods of producing same | |
GB1147803A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
GB1146992A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
GB1158332A (en) | New 7alpha-Methyl-19-Nor-Androstadienes and process for their Manufacture | |
US3356677A (en) | 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes | |
US3127428A (en) | Process for converting a 3-keto-delta-steroid to the corresponding 3-keto delta-compound | |
GB928805A (en) | Steroid compounds | |
US3312720A (en) | 3-desoxy-19-nor-androstenes | |
GB984839A (en) | Steroid compounds | |
US3026339A (en) | 9, 11-dihalogeno substituted steroids of the androstane series | |
GB962858A (en) | 17ª-chlorethynyl steroids and process for the preparation thereof | |
GB971608A (en) | 17ª-methyl steroids and their production and use | |
US3424769A (en) | Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids | |
US3033859A (en) | Process for the manufacture of oxido-steroids | |
US3213117A (en) | Process for preparation of delta1(10)-5alpha-estren-17beta-ol-2-one and derivatives thereof | |
US3126398A (en) | Fluorevated androstenes and process | |
GB1378168A (en) | 6alpha-fluoro-16alpha,18-dimethyl-delta1,4-pregnadiene-3,20-diones | |
US3485848A (en) | 6beta-alkoxy-10beta-carboxyl-3alpha,5-cyclosteroids | |
GB761490A (en) | Steroid production | |
GB1208881A (en) | Improvements in or relating to the preparation of 09-nor steroids and intermediates thereof | |
US3274183A (en) | 3-(17beta-hydroxy-1, 4-dimethylestra-1, 3, 5(10)-trien-17alpha-yl) propionic acid lactone and intermediates | |
US3048605A (en) | 16, 16-difluoroestratrienes | |
GB969300A (en) | New steroids of the androstane series and process for their production | |
GB1192061A (en) | Steroidal 1,4-Dienes |